Protagonist Therapeutics (PTGX) Asset Utilization Ratio (2018 - 2026)

Protagonist Therapeutics has reported Asset Utilization Ratio for 9 years, with the latest figure at 0.11 in Q1 2026.

• Quarterly Asset Utilization Ratio fell 60.11% year-over-year to 0.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.11 (down 60.11% YoY) and the FY2025 annual result came in at 0.07, down 91.73% from the prior year.
• Asset Utilization Ratio rose to 0.11 in Q1 2026 per PTGX's latest filing, from 0.07 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.64 in Q4 2024 and troughed at 0.0 in Q1 2023.
• A 5-year average of 0.26 and a median of 0.15 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio sank 97.39% in 2023, then surged 17440.91% in 2024.
• Over 5 years, Asset Utilization Ratio stood at 0.1 in 2022, then soared by 44.94% to 0.15 in 2023, then surged by 337.49% to 0.64 in 2024, then plunged by 89.44% to 0.07 in 2025, then surged by 61.45% to 0.11 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.11, 0.07, and 0.29 for Q1 2026, Q4 2025, and Q3 2025 respectively.